Sentinel lymph node biopsy in impalpable breast cancer

Area of Science:

• Oncology
• Surgical Pathology
• Nuclear Medicine

Background:

• Accurate staging of breast cancer is crucial for effective treatment planning.
• Sentinel lymph node biopsy (SLNB) is a key technique for assessing axillary lymph node metastasis.
• Application of SLNB in impalpable breast cancers requires reliable detection methods.

Purpose of the Study:

• To evaluate the efficacy of combined radioactive colloid and vital blue dye for sentinel lymph node identification in patients with impalpable breast cancers.
• To determine the accuracy of sentinel lymph node biopsy in detecting metastasis in this specific patient group.

Main Methods:

• A prospective study involving 27 patients with impalpable breast cancers.
• Sentinel lymph nodes were identified using a combination of radioactive colloid and vital blue dye injection.
• Surgical excision and pathological examination of identified sentinel nodes were performed.

Main Results:

• Sentinel lymph nodes were successfully identified in 25 out of 27 patients (93% identification rate).
• Of the seven patients with lymph node involvement, all had a positive sentinel node.
• The combined technique demonstrated high sensitivity and accuracy in detecting metastatic disease.

Conclusions:

• Combined radioactive colloid and vital blue dye sentinel lymph node biopsy is a highly effective method for staging impalpable breast cancers.
• This technique provides accurate assessment of lymph node status, guiding subsequent treatment decisions.
• Sentinel lymph node biopsy is ideally suited for breast cancer cases where lymph nodes are not clinically palpable.